Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine.
paper
Cited
Public
Unavailable
- Authors
- Henningfield, J E; Miyasato, K; Jasinski, D R
- Year
- 1985
- Journal
- The Journal of pharmacology and experimental therapeutics
- PMID
- 4009494
The potential role of nicotine in tobacco dependence was investigated using the strategies of abuse liability assessment. Eight male volunteer cigarette smokers with histories of drug abuse resided on a research ward for the duration of the study. Each subject was tested with three doses of i.v. nicotine (0.75, 1.5 and 3.0 mg/10-sec infusion) and placebo each test day, and with three doses of inhaled nicotine, in the form of research cigarette smoke (0.4, 1.4 and 2.9 mg estimated yield) and placebo (sham-smoking), given on alternate test days. Each subject was tested on 4 days with both routes of administration, according to identical experimental protocols. Physiologic, subjective and observer data were collected at intervals ranging from 15 sec to 10 min beginning 10 min before drug administration and continuing for 30 min after administration. Both i.v. and inhaled nicotine produced dose-related increases in heart rate and blood pressure, and i.v. nicotine produced a transient bradycardia in four subjects during the first 30 sec after drug administration. Skin temperature was decreased by nicotine and pupil diameter was not consistently changed. Ratings of drug dose "strength" and drug "liking" were directly related to dose level whereas "desire to smoke cigarettes" was inversely related. Scores on the Morphine-Benzedrine Group (or Euphoria) scale of the Addiction Research Center Inventory were elevated by nicotine, and i.v. doses were identified frequently as cocaine. Signs and symptoms were similar for nicotine across the two routes of administration and included coughing, dizziness, nausea and relaxed feelings. Nicotine shared the pharmacologic profile of prototypic drugs of abuse. The study supports the hypothesis that the role of nicotine in tobacco dependence is equivalent to the role of other psychoactive drugs in substance abuse, e.g., to the role of cocaine in coca leaf use.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| The genetics of substance dependence. | 2012 | 22703173 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics. | Henningfield JE et al. | — | 2026 | → |
| Adolescent nicotine exposure affects later-life nicotine reward and withdrawal in mice. | Buzzi B et al. | — | 2025 | → |
| Assessment of human abuse potential of an unflavored, sucralose-sweetened electronic cigarette in combustible cigarette smokers. | Maloney SF et al. | — | 2024 | → |
| Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial. | Lengsfeld S et al. | — | 2023 | → |
| Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)-a structured summary of a study protocol for a randomized controlled study. | Lengsfeld S et al. | — | 2023 | → |
| Identification of Pathogenic Missense Mutations in the CHRNA5 Gene: A Computational Approach. | Kumaraguru M et al. | — | 2023 | → |
| Smoking cessation and vaccination. | Montes de Oca M et al. | — | 2023 | → |
| Effects of Prenatal Nicotine, THC, or Co-Exposure on Cognitive Behaviors in Adolescent Male and Female Rats. | Lallai V et al. | — | 2022 | → |
| Acute subjective sensory perceptions predict relative reinforcing effects of smoked nicotine. | Karelitz JL et al. | — | 2021 | → |
| Attenuating nicotine's effects with high affinity human anti-nicotine monoclonal antibodies. | Raleigh MD et al. | — | 2021 | → |
| Nicotine e-cigarette vapor inhalation and self-administration in a rodent model: Sex- and nicotine delivery-specific effects on metabolism and behavior. | Lallai V et al. | — | 2021 | → |
| More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder. | Moerke MJ et al. | — | 2020 | → |
| Structural Insights into 6-Hydroxypseudooxynicotine Amine Oxidase from <i>Pseudomonas geniculata</i> N1, the Key Enzyme Involved in Nicotine Degradation. | Liu G et al. | — | 2020 | → |
| Understanding the neurobiological effects of drug abuse: Lessons from zebrafish models. | Müller TE et al. | — | 2020 | → |
| Discrimination of nicotine content in electronic cigarettes. | Perkins KA et al. | — | 2019 | → |
| Sex differences in the reward deficit and somatic signs associated with precipitated nicotine withdrawal in rats. | Tan S et al. | — | 2019 | → |
| Metabotropic Glutamate Receptors 2 and 3 as Targets for Treating Nicotine Addiction. | Cross AJ et al. | — | 2018 | → |
| Response dynamics of midbrain dopamine neurons and serotonin neurons to heroin, nicotine, cocaine, and MDMA. | Wei C et al. | — | 2018 | → |
| Endogenous opioid system: a promising target for future smoking cessation medications. | Norman H et al. | — | 2017 | → |
| Joint trajectories of cigarette smoking and depressive symptoms from the mid-20s to the mid-30s predicting generalized anxiety disorder. | Lee JY et al. | — | 2017 | → |
| Psychological and Familial Factors of Depression in Relation to Adolescent Smoking Behavior. | Roohafza H et al. | — | 2017 | → |
| Effect of Menthol-preferring Status on Response to Intravenous Nicotine. | DeVito EE et al. | — | 2016 | → |
| Effects of nicotine in combination with drugs described as positive allosteric nicotinic acetylcholine receptor modulators in vitro: discriminative stimulus and hypothermic effects in mice. | Moerke MJ et al. | — | 2016 | → |
| Factors associated with depression among elderly Koreans: the role of chronic illness, subjective health status, and cognitive impairment. | Park JI et al. | — | 2016 | → |
| Central administration of nicotine suppresses tracheobronchial cough in anesthetized cats. | Poliacek I et al. | — | 2015 | → |
| Molecular mechanism of nicotine degradation by a newly isolated strain, Ochrobactrum sp. strain SJY1. | Yu H et al. | — | 2015 | → |
| Physical activity and nicotine dependence among a national sample of young U.S. adults who smoke daily: evaluation of cross-sectional and longitudinal associations to determine which behavior drives this relationship. | Loprinzi PD et al. | — | 2015 | → |
| Enhanced nicotine self-administration and suppressed dopaminergic systems in a rat model of diabetes. | O'Dell LE et al. | — | 2014 | → |
| Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation. | Li X et al. | — | 2014 | → |
| Lack of Association between the Serotonin Transporter (5-HTT) and Serotonin Receptor (5-HT2A) Gene Polymorphisms with Smoking Behavior among Malaysian Malays. | Rozak NI et al. | — | 2014 | → |
| A translational pharmacology approach to understanding the predictive value of abuse potential assessments. | Horton DB et al. | — | 2013 | → |
| Neuronal nicotinic receptors as analgesic targets: it's a winding road. | Umana IC et al. | — | 2013 | → |
| Nicotine levels after IV nicotine and cigarette smoking in men. | Mello NK et al. | — | 2013 | → |
| Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats. | Jutkiewicz EM et al. | — | 2013 | → |
| The "stop" and "go" of nicotine dependence: role of GABA and glutamate. | D'Souza MS et al. | — | 2013 | → |
| Decreasing Nicotine Content Reduces Subjective and Physiological Effects of Smoking. | Penetar DM et al. | — | 2012 | → |
| Developing a Rational Approach to Tobacco Use Treatment in Pulmonary Practice: A Review of the Biological Basis of Nicotine Addiction. | Leone FT et al. | — | 2012 | → |
| Nicotine vaccines to assist with smoking cessation: current status of research. | Raupach T et al. | — | 2012 | → |
| Smoking, quitting, and psychiatric disease: a review. | Aubin HJ et al. | — | 2012 | → |
| The genetics of substance dependence. | Wang JC et al. | — | 2012 | → |
| Acute nicotine-induced tachyphylaxis is differentially manifest in the limbic system. | Zuo Y et al. | — | 2011 | → |
| Cigarette smoking in outpatients with chronic schizophrenia in Taiwan: relationships to socio-demographic and clinical characteristics. | Kao YC et al. | — | 2011 | → |
| Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. | D'Souza MS et al. | — | 2011 | → |
| [Pharmacotherapeutic treatment strategies for smoking cessation]. | Vasic N et al. | — | 2011 | → |
| The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition. | Lotfipour S et al. | — | 2011 | → |
| The predictive validity of the rat self-administration model for abuse liability. | O'Connor EC et al. | — | 2011 | → |
| Clinical experience of varenicline for smoking cessation. | Jung JW et al. | — | 2010 | → |
| Critical care support of patients with nicotine addiction. | Afessa B et al. | — | 2010 | → |
| Fundamental reaction pathways for cytochrome P450-catalyzed 5'-hydroxylation and N-demethylation of nicotine. | Li D et al. | — | 2010 | → |
| Smoking cessation. | Chandler MA et al. | — | 2010 | → |
| The Role of Genetics in Nicotine Dependence: Mapping the Pathways from Genome to Syndrome. | Mackillop J et al. | — | 2010 | → |
| Abuse liability assessment of tobacco products including potential reduced exposure products. | Carter LP et al. | — | 2009 | → |
| Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function. | Edgar CJ et al. | — | 2009 | → |
| Effects of nicotine in experimental animals and humans: an update on addictive properties. | Le Foll B et al. | — | 2009 | → |
| Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population. | Sieminska A et al. | — | 2009 | → |
| Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. | Sofuoglu M et al. | — | 2009 | → |
| Respiratory sensations evoked by activation of bronchopulmonary C-fibers. | Lee LY | — | 2009 | → |
| Subjective responses to intravenous nicotine: greater sensitivity in women than in men. | Sofuoglu M et al. | — | 2009 | → |
| The serotonin 2A receptor gene in alcohol dependence and tobacco smoking. | Polina ER et al. | — | 2009 | → |
| Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers. | McColl SL et al. | — | 2008 | → |
| Neurobiology of nicotine addiction: implications for smoking cessation treatment. | Benowitz NL | — | 2008 | → |
| Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent. | Mwenifumbo JC et al. | — | 2008 | → |
| Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism. | Ring HZ et al. | — | 2007 | → |
| Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. | Mwenifumbo JC et al. | — | 2007 | → |
| High reinforcing efficacy of nicotine in non-human primates. | Le Foll B et al. | — | 2007 | → |
| Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking. | Mwenifumbo JC et al. | — | 2007 | → |
| The association of nicotine replacement therapy with mortality in a medical intensive care unit. | Lee AH et al. | — | 2007 | → |
| Changes in maternal and fetal nicotine distribution after maternal administration of monoclonal nicotine-specific antibody to rats. | Keyler DE et al. | — | 2006 | → |
| Differential effects of passive immunization with nicotine-specific antibodies on the acute and chronic distribution of nicotine to brain in rats. | Pentel PR et al. | — | 2006 | → |
| Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers. | Sofuoglu M et al. | — | 2006 | → |
| Nicotine and nonnicotine factors in cigarette addiction. | Rose JE | — | 2006 | → |
| Nicotine as a typical drug of abuse in experimental animals and humans. | Le Foll B et al. | — | 2006 | → |
| Nicotine psychopharmacology research contributions to United States and global tobacco regulation: a look back and a look forward. | Henningfield JE et al. | — | 2006 | → |
| Cholecystokinin (CCK) and the CCKA receptor gene polymorphism, and smoking behavior. | Takimoto T et al. | — | 2005 | → |
| Effect of application sites and multiple doses on nicotine pharmacokinetics in healthy male Japanese smokers following application of the transdermal nicotine patch. | Sobue S et al. | — | 2005 | → |
| Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers. | Sofuoglu M et al. | — | 2005 | → |
| Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. | Malaiyandi V et al. | — | 2005 | → |
| Metabolism of nicotine and cotinine by human cytochrome P450 2A13. | Bao Z et al. | — | 2005 | → |
| Nicotine use in schizophrenia: the self medication hypotheses. | Kumari V et al. | — | 2005 | → |
| Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography. | Vaupel DB et al. | — | 2005 | → |
| Transdermal nicotine alters some of marihuana's effects in male and female volunteers. | Penetar DM et al. | — | 2005 | → |
| Clinical features of nicotine dependence compared with those of alcohol, methamphetamine, and inhalant dependence. | Miyata H et al. | — | 2004 | → |
| Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. | Harvey DM et al. | — | 2004 | → |
| Treatment of stable chronic obstructive pulmonary disease. | Rennard SI | — | 2004 | → |
| [Update on the treatment of tobacco dependence]. | Sampablo Lauro I et al. | — | 2004 | → |
| Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166). | Chausmer AL et al. | — | 2003 | → |
| Hospital- and clinic-based smoking cessation interventions for smokers with cardiovascular disease. | Thomson CC et al. | — | 2003 | → |
| Intravenous nicotine reduces cerebral glucose metabolism: a preliminary study. | Stapleton JM et al. | — | 2003 | → |
| Tissue-dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats. | Satoskar SD et al. | — | 2003 | → |
| CYP2A6 genetic variation and potential consequences. | Xu C et al. | — | 2002 | → |
| Effects of whole deletion of CYP2A6 on nicotine metabolism in humans. | Zhang X et al. | — | 2002 | → |
| Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. | Tyndale RF et al. | — | 2002 | → |
| Genotyping human CYP2A6 variants. | Goodz SD et al. | — | 2002 | → |
| Restricted daily access to water and voluntary nicotine oral consumption in mice: methodological issues and individual differences. | Adriani W et al. | — | 2002 | → |
| The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence. | Howard LA et al. | — | 2002 | → |
| Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers. | Garrett BE et al. | — | 2001 | → |
| Vaccines against nicotine: how effective are they likely to be in preventing smoking? | Vocci FJ et al. | — | 2001 | → |
| Cigarettes and suicide: a prospective study of 50,000 men. | Miller M et al. | — | 2000 | → |
| Functional variants at CYP2A6: new genotyping methods, population genetics, and relevance to studies of tobacco dependence. | Zabetian CP et al. | — | 2000 | → |
| Smoking cessation. | Rennard SI et al. | — | 2000 | → |
| Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain. | Hieda Y et al. | — | 2000 | → |
| A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumption. | Tyndale RF et al. | — | 1999 | → |
| Altered disposition of repeated nicotine doses in rats immunized against nicotine. | Keyler DE et al. | — | 1999 | → |
| Blockade of nicotine self-administration with nicotinic antagonists in rats. | Watkins SS et al. | — | 1999 | → |
| Blowing smoke: how cigarette manufacturers argued that nicotine is not addictive. | Sharfstein J | — | 1999 | → |
| The development of cross-tolerance between morphine and nicotine in mice. | Zarrindast MR et al. | — | 1999 | → |
| COPD: overview of definitions, epidemiology, and factors influencing its development. | Rennard SI | — | 1998 | → |
| Gender differences in the pharmacology of nicotine addiction. | Benowitz NL et al. | — | 1998 | → |
| Incorporating nicotine dependence into addiction treatment. | Rustin TA | — | 1998 | → |
| Phagocytic function of salivary PMN after smoking or secondary smoking. | Numabe Y et al. | — | 1998 | → |
| Relationship of cessation of cocaine use to cigarette smoking in cocaine-dependent outpatients. | Wiseman EJ et al. | — | 1998 | → |
| Nicotine-containing versus de-nicotinized cigarettes: effects on craving and withdrawal. | Gross J et al. | — | 1997 | → |
| Smokeless tobacco: an addicting drug. | Henningfield JE et al. | — | 1997 | → |
| Smoking among suicide attempters. | Beratis S et al. | — | 1997 | → |
| Acute tolerance to nicotine in smokers: lack of dissipation within 2 hours. | Perkins KA et al. | — | 1995 | → |
| Marshaling the evidence for greater regulation and control of tobacco products: A call for action. | Kaplan RM et al. | — | 1995 | → |
| Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers. | Butschky MF et al. | — | 1995 | → |
| Subjective and cardiovascular responses to nicotine combined with alcohol in male and female smokers. | Perkins KA et al. | — | 1995 | → |
| The addictive role of nicotine in tobacco use. | Henningfield JE et al. | — | 1995 | → |
| Caffeine antagonizes EEG effects of tobacco withdrawal. | Cohen C et al. | — | 1994 | → |
| Comparison of acute subjective and heart rate effects of nicotine intake via tobacco smoking versus nasal spray. | Perkins KA et al. | — | 1994 | → |
| Nicotine discrimination in male and female smokers. | Perkins KA et al. | — | 1994 | → |
| Preference for high- versus low-potency marijuana. | Chait LD et al. | — | 1994 | → |
| Subjective and cardiovascular responses to nicotine combined with caffeine during rest and casual activity. | Perkins KA et al. | — | 1994 | → |
| Transdermal nicotine: reduction of smoking with minimal abuse liability. | Pickworth WB et al. | — | 1994 | → |
| Chronic and acute tolerance to subjective effects of nicotine. | Perkins KA et al. | — | 1993 | → |
| Lack of effect of cimetidine on cigarette smoking. | Bendayan R et al. | — | 1993 | → |
| Measuring the stages of change in cigarette smokers. | Rustin TA et al. | — | 1993 | → |
| Affect regulation, nicotine addiction, and smoking cessation. | Carmody TP | — | 1992 | → |
| Nasal nicotine spray: a rapid nicotine delivery system. | Sutherland G et al. | — | 1992 | → |
| Smoking cessation in women: effects of the menstrual cycle. | Craig D et al. | — | 1992 | → |
| The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. | Corrigall WA et al. | — | 1992 | → |
| The role of nicotine in tobacco use. | Robinson JH et al. | — | 1992 | → |
| Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium. | Miller DB et al. | — | 1991 | → |
| History of abuse liability testing in humans. | Jasinski DR | — | 1991 | → |
| The necessity and utility of abuse liability evaluations in human subjects. | Vocci FJ | — | 1991 | → |
| The neurobiology of tobacco addiction. | Stolerman IP et al. | — | 1991 | → |
| Conditioned aversion after delay place conditioning with amphetamine. | Fudala PJ et al. | — | 1990 | → |
| Diazepam abuse in pregnant women on methadone maintenance. Implications for the neonate. | Sutton LR et al. | — | 1990 | → |
| Effect of cimetidine and ranitidine on the hepatic and renal elimination of nicotine in humans. | Bendayan R et al. | — | 1990 | → |
| Nicotine dependence: a preventable risk factor for other diseases. | Cohen C et al. | — | 1990 | → |
| Withdrawal from chronic nicotine fails to produce a conditioned taste aversion to saccharin in rats. | Villanueva HF et al. | — | 1990 | → |
| Affect regulation, nicotine addiction, and smoking cessation. | Carmody TP | — | 1989 | → |
| An interpretative review of smokeless tobacco research in the United States: Part II. | Glover ED et al. | — | 1989 | → |
| Clinical pharmacokinetics of non-opiate abused drugs. | Busto U et al. | — | 1989 | → |
| Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. | Benowitz NL | — | 1988 | → |
| Nicotine dependence. Interface between tobacco and tobacco-related disease. | Henningfield JE et al. | — | 1988 | → |
| Pharmacologic determinants of tobacco self-administration by humans. | Henningfield JE et al. | — | 1988 | → |
| Smoking and mechanisms of cardiovascular control. | Robertson D et al. | — | 1988 | → |
| Citric acid aerosol as a potential smoking cessation aid. | Rose JE et al. | — | 1987 | → |
| Nicotine and smoking: a perspective from animal studies. | Clarke PB | — | 1987 | → |
| Nicotine gum: dose-related effects on cigarette smoking and subjective ratings. | Nemeth-Coslett R et al. | — | 1987 | → |
| Electroencephalographic effects of nicotine chewing gum in humans. | Pickworth WB et al. | — | 1986 | → |
| Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General. | Cullen JW et al. | — | 1986 | → |
| The reemergence of smokeless tobacco. | Connolly GN et al. | — | 1986 | → |